Pa. Crooks et al., METABOLITES OF NICOTINE IN RAT-BRAIN AFTER PERIPHERAL NICOTINE ADMINISTRATION - COTININE, NORNICOTINE, AND NORCOTININE, Drug metabolism and disposition, 25(1), 1997, pp. 47-54
The time course of nicotine metabolite appearance in brain from 5 min-
18 hr after subcutaneous administration of S-(-)-[H-3-N-methyl]nicotin
e was determined. Results demonstrated that metabolite appearance in b
rain was greatest at 4 hr postadministration, whereas levels of nicoti
ne were greatly diminished at this time point. For determination of N-
demethylated metabolites, (+/-)-[2'-C-14]nicotine was administered sub
cutaneously to rats, and the presence of nicotine and nicotine metabol
ites in brain supernatant was determined 4 hr postadministration. Usin
g high-performance liquid radiochromatographic analysis, nicotine and
three nicotine metabolites (cotinine, nornicotine, and norcotinine) we
re identified in brain, together with a fourth minor, unidentified met
abolite. After subcutaneous administration of S-(-)-[G-H-3]cotinine, s
ignificant amounts of cotinine were found in brain over an 18-hr posta
dministration period; however, no cotinine metabolites were detected.
Therefore, cotinine is able to pass the blood-brain barrier and access
the central nervous system, but is not biotransformed in brain. Thus,
this is the first report of norcotinine as a central nervous system n
icotine metabolite. Data indicate that norcotinine detected in brain a
fter peripheral nicotine administration most likely originates from 5'
-C-oxidation of brain nornicotine, rather than from N-demethylation of
cotinine, as occurs peripherally. Because peripheral biotransformatio
n of nicotine to nornicotine is a minor pathway, the relatively high l
evels of nornicotine found in brain after peripheral nicotine administ
ration suggest that nornicotine is formed via oxidative N-demethylatio
n of nicotine locally in brain. Nornicotine is pharmacologically activ
e; thus, its presence in brain after peripheral nicotine administratio
n indicates that nornicotine may contribute to the neuropharmacologica
l effects of nicotine and tobacco use.